Explore clinical trials. Start with your story.
Start with your story. AI helps organize the details. Our team helps you take the next step.
A clearer starting point. People to help you move forward.
A useful conversation should lead somewhere. Each stage has a distinct role, from understanding your situation to checking a possible opportunity.
- 01
You + AI
Start with your situation
Bring your questions and available reports. Build a clearer picture of your diagnosis, treatment history, and priorities.
An organized starting point - 02
Chirona team
Review with our team
A person reviews the information, identifies what is missing, and examines which research options merit further enquiry.
A considered shortlist - 03
Research team
Confirm with the center
The trial team confirms availability, reviews eligibility, and explains any assessments needed before enrolment.
A verified next step
An initial match is an invitation to investigate further. It is not a guarantee of eligibility or enrolment.
The right questions make the difference.
A trial name is only the beginning. A meaningful review connects research requirements with your medical history and everyday circumstances.
Prepare your medical informationYour diagnosis in detail
Cancer type, pathology, stage, and molecular findings help define which studies may be relevant. Missing or unclear findings need to be resolved rather than guessed.
The treatments you have received
Previous treatments, their timing, and the current disease situation matter when comparing a patient's history with a study's inclusion and exclusion criteria.
The study's actual requirements
Age, organ function, laboratory results, and other protocol-specific conditions may affect eligibility. The research team must confirm how these apply to an individual.
The practical ability to participate
Location, appointment frequency, follow-up, travel, and costs deserve attention alongside medical criteria. These details need confirmation with the relevant center.
Public evidence. Clear sources. Further verification.
Published records inform exploration. Availability and individual eligibility still need confirmation with the research team.
Reference resources, not a statement of partnership or live data integration.
Reviewers, centers, and the scope of support are confirmed for each enquiry. The study investigator decides eligibility.
Technology helps you begin. People help you move forward.
Your questions deserve someone who can follow through. Human review and coordination are central to our service.
Medical information review
Clarify missing information and prepare questions for professional assessment.
Research-center coordination
Enquire about availability and screening requirements, with your authorization to share relevant information.
Patient communication
Explain feedback and next steps, including when no suitable option has been identified.
Know where things stand. Know what comes next.
A clear review process makes room for questions, missing information, and honest answers. Explore the stages below.
Bring the picture together
Available reports and your priorities are reviewed together. Information needed for the next step is identified.
A service overview, not a live case tracker. Timelines and participation depend on the study and center.
A little context, when you need it.
Start a conversation now, or take time to understand the questions first.
Before you begin.
Patient information reference
National Cancer Institute: finding a clinical trialWhat is a cancer clinical trial?
A clinical trial is a research study involving people. Cancer treatment trials investigate new treatments, combinations, or ways of using existing treatments. Benefits and risks depend on the study; an investigational treatment is not guaranteed to be better than standard care.
Does an AI match mean I can join a trial?
No. AI-assisted exploration can organize information and identify questions or research directions. Professional review and the trial team's screening are still needed. The responsible study team confirms eligibility and enrolment.
Can I start without all my medical reports?
You can start with what you know and the help you want. Pathology, treatment summaries, imaging, and molecular results may be useful later. Missing information should be marked as unknown and clarified during review.
Can I enquire on behalf of a family member?
Yes. Explain your relationship and what help you are seeking. Obtain the patient's permission before sharing medical information. Any authorization needed for further assessment or center contact can be clarified with the team.
What costs might a clinical trial involve?
Costs vary. A study may cover some research-related costs while routine care, travel, accommodation, or other expenses remain payable. Ask the center for study-specific costs.
What happens if no suitable trial is found?
The outcome should be explained, including whether information is missing, study requirements do not fit, or availability could not be confirmed. No suitable option is a valid outcome of review. Discuss subsequent treatment decisions with your doctor.
What happens to information in this conversation?
The text you send and the context needed to reply are processed by our AI service and saved in your Chirona conversation. Guests access conversations through a browser cookie; signing in links conversations from that browser to your account. Only after you review and confirm sharing does the human team receive the summary, feedback, listed attachments and account email to create a case. The team does not receive your full chat history. The separate consultation form has its own consent process.
You do not have to figure it all out alone.
Start with what you know. We can take the questions one at a time.
For information and service navigation, not diagnosis or medical advice. Trial participation requires study-team assessment. No enrolment or treatment outcome is guaranteed.